HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Ishikawa Selected Research

Pilomatrixoma

1/2020Six cases of perforating pilomatricoma: Anetodermic changes with expression of matrix metalloproteinases.
4/2018Pilomatricoma with bullous-like/anetodermic appearance: Possibly associated with matrix metalloproteinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Ishikawa Research Topics

Disease

98Neoplasms (Cancer)
11/2020 - 03/2002
42Pancreatic Neoplasms (Pancreatic Cancer)
07/2020 - 07/2003
23Systemic Scleroderma (Systemic Sclerosis)
07/2021 - 01/2006
23Adenocarcinoma
03/2015 - 03/2002
21Neoplasm Metastasis (Metastasis)
11/2014 - 07/2002
18Esophageal Neoplasms (Esophageal Cancer)
01/2017 - 09/2002
14Hepatocellular Carcinoma (Hepatoma)
08/2015 - 03/2002
13Psoriasis (Pustulosis Palmaris et Plantaris)
08/2021 - 07/2002
12Stomach Neoplasms (Stomach Cancer)
01/2014 - 03/2004
10Fibrosis (Cirrhosis)
07/2021 - 10/2003
9Interstitial Lung Diseases (Interstitial Lung Disease)
02/2022 - 03/2010
9Dermatomyositis (Dermatopolymyositis)
11/2021 - 08/2016
8Sclerosis
01/2019 - 07/2002
8Lymphatic Metastasis
11/2015 - 01/2003
8Rectal Neoplasms (Rectal Cancer)
11/2013 - 10/2005
7Wounds and Injuries (Trauma)
08/2019 - 07/2009
7digital ulcers
03/2018 - 07/2008
7Melanoma (Melanoma, Malignant)
01/2017 - 06/2003
6Reperfusion Injury
07/2021 - 03/2015
6Pressure Ulcer (Bedsore)
07/2021 - 01/2016
6Hypoxia (Hypoxemia)
01/2019 - 06/2003
6Pancreatic Fistula (Pancreatic Fistulas)
10/2017 - 07/2008
6Thrombosis (Thrombus)
01/2016 - 09/2004
6Carcinogenesis
01/2016 - 02/2004
6Colorectal Neoplasms (Colorectal Cancer)
04/2013 - 02/2004
5Suppuration
01/2020 - 01/2016
5Carcinoma (Carcinomatosis)
01/2012 - 04/2002
5Colonic Neoplasms (Colon Cancer)
12/2010 - 01/2004
4Disease Progression
08/2021 - 03/2007
4Fever (Fevers)
01/2021 - 01/2006
4Ischemia
01/2020 - 04/2005
4Eosinophilia
01/2019 - 11/2007
4Pathologic Constriction (Stenosis)
11/2018 - 07/2009
4Necrosis
01/2016 - 10/2005
4Drug Eruptions (Drug Eruption)
11/2011 - 01/2006
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2021 - 07/2008
3Hemorrhage
08/2021 - 05/2002
3Angioedema
01/2021 - 07/2013
3Dermatofibrosarcoma
12/2019 - 08/2012
3Nephrogenic Fibrosing Dermopathy
01/2019 - 04/2011
3Liver Cirrhosis (Hepatic Cirrhosis)
02/2017 - 06/2006
3Gallbladder Neoplasms (Gallbladder Cancer)
12/2015 - 03/2005
3Skin Diseases (Skin Disease)
08/2015 - 08/2008
3Body Weight (Weight, Body)
12/2014 - 01/2006

Drug/Important Bio-Agent (IBA)

18GemcitabineFDA Link
09/2019 - 06/2007
12Proteins (Proteins, Gene)FDA Link
02/2022 - 05/2003
9AntibodiesIBA
02/2022 - 06/2003
8Complementary DNA (cDNA)IBA
05/2014 - 02/2004
8Indicators and Reagents (Reagents)IBA
01/2014 - 07/2003
7Pharmaceutical PreparationsIBA
12/2020 - 11/2006
7Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2011 - 02/2006
6DNA (Deoxyribonucleic Acid)IBA
02/2022 - 11/2002
6Biological ProductsIBA
07/2020 - 04/2005
6Small Interfering RNA (siRNA)IBA
10/2018 - 03/2007
61 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA
10/2010 - 02/2005
6Ointments (Pastes)IBA
04/2009 - 02/2005
5Bleomycin (Blenoxane)FDA LinkGeneric
07/2021 - 10/2018
5Botulinum Toxins (Botulinum Toxin)IBA
07/2021 - 07/2017
5Interleukin-6 (Interleukin 6)IBA
01/2019 - 08/2008
5LigandsIBA
01/2019 - 01/2004
5Bosentan (Tracleer)FDA Link
01/2012 - 01/2006
5Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2011 - 06/2008
4batrachotoxinin A 20-alpha-benzoateIBA
07/2021 - 07/2017
4CytokinesIBA
01/2021 - 03/2008
4Carcinoembryonic AntigenIBA
12/2018 - 01/2008
4Tumor Biomarkers (Tumor Markers)IBA
12/2010 - 03/2004
4Hormones (Hormone)IBA
06/2006 - 05/2003
3Coloring Agents (Dyes)IBA
06/2022 - 06/2008
3Glycoproteins (Glycoprotein)IBA
02/2022 - 07/2014
3Biomarkers (Surrogate Marker)IBA
09/2020 - 10/2009
3Imatinib Mesylate (Gleevec)FDA Link
06/2020 - 01/2010
3Matrix Metalloproteinases (MMPs)IBA
01/2020 - 04/2015
3CollagenIBA
01/2020 - 07/2009
3Collagen Type I (Type I Collagen)IBA
01/2019 - 06/2003
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 07/2002
3Messenger RNA (mRNA)IBA
12/2018 - 06/2003
3Type A Botulinum Toxins (Botox)FDA Link
05/2018 - 03/2015
3Immunoglobulins (Immunoglobulin)IBA
05/2018 - 03/2010
3anti-scl-70 autoantibodiesIBA
01/2017 - 07/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 07/2013
3AcidsIBA
11/2015 - 09/2012
3AmylasesFDA Link
10/2015 - 07/2008

Therapy/Procedure

55Therapeutics
01/2021 - 07/2002
26Drug Therapy (Chemotherapy)
09/2019 - 07/2002
15Radiotherapy
10/2018 - 03/2002
10Neoadjuvant Therapy
12/2019 - 01/2009
10Hepatectomy
12/2015 - 05/2002
10Pancreatectomy
10/2015 - 04/2002
10Lymph Node Excision (Lymph Node Dissection)
07/2013 - 01/2003
9Chemoradiotherapy
03/2016 - 10/2005
9Esophagectomy
11/2015 - 03/2004
9Gastrectomy
01/2014 - 02/2005
7Pancreaticoduodenectomy
08/2021 - 04/2002
7Stents
11/2020 - 10/2005
4Laparotomy
05/2012 - 03/2004
3Catheters
12/2020 - 11/2010
3Operative Surgical Procedures
10/2019 - 07/2006
3Injections
10/2018 - 03/2008
3Subcutaneous Injections
06/2018 - 06/2017
3Combined Modality Therapy
12/2016 - 05/2012